Calcium-ion-modulated ceramic hydroxyapatite resin for the scalable purification of recombinant Adeno-Associated Virus serotype 9

被引:6
|
作者
Qu, Weihong [1 ,2 ,4 ]
Wang, Mingxi [1 ,2 ,3 ]
Wu, Yaqing [1 ,2 ,3 ]
Lv, Yinghui [1 ,2 ,3 ]
Wang, Qizhao [1 ,2 ,3 ]
Xu, Ruian [1 ,2 ,3 ]
机构
[1] Huaqiao Univ, Sch Med, Quanzhou 361021, Fujian, Peoples R China
[2] Huaqiao Univ, Inst Mol Med, Quanzhou 361021, Fujian, Peoples R China
[3] Minist Educ, Engn Res Ctr Mol Med, Xiamen 361021, Fujian, Peoples R China
[4] Jiujiang Univ, Coll Med & Life Sci, Jiujiang 332000, Jiangxi, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2015年 / 990卷
基金
中国国家自然科学基金;
关键词
Calcium ion; Ceramic hydroxyapatite resin; Scalable purification; rAAV9; MANUFACTURING PRACTICE PRODUCTION; GENE-TRANSFER; ALIPOGENE TIPARVOVEC; ADENOVIRAL VECTORS; IMMUNE-RESPONSES; KALLISTATIN; HEMOPHILIA; ANGIOGENESIS; EXCHANGE; THERAPY;
D O I
10.1016/j.jchromb.2015.03.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Column chromatography has been widely used as a scalable purification strategy for recombinant adeno-associated virus (rAAV) vectors. The rAAV1, 2, 4, 5, 6, 8 and 9 serotypes could be separated using affinity resins, ion exchange resins or other types of resins. Apatite resin has displayed outstanding performance in protein purification in the past 10 years, and ceramic hydroxyapatite (CHT) chromatography resin with a polyethylene glycol (PEG) modulation has recently been used for rAAV1 and rAAV9 vectors. This study reports the use of CHT chromatography modulated by calcium ions instead of PEG for rAAV9 purification. Calcium-ion-containing buffers effectively improve the inclusion of CHT as a capture resin, the resin-binding capacity and the yield. The optimum calcium ion concentration is 30 ppm, and the optimum pH is 7.0. A frontal analysis indicated that the binding capacity of CHT at 2 ml/min reaches 65.1 mg total protein per ml of resin. A previously developed purification strategy consists of CHT followed by ANX anion exchange chromatography. The vector yield of this approach is approximately 70%, and a software analysis indicated a vector purity exceeding 98%. The residual host cell (HEK293) protein contents are 24.75 +/- 2.32 ng and 67.21 +/- 2.10 ng, and the Benzonase residue contents are 1.55 +/- 0.10 pg and 1.95 +/- 0.16 ng per 1013 vector genome copies (G.C.) separated by CHT/ANX and CsCl. In addition, CHT/ANX yields 798.44 +/- 50.10 pg of plasmid DNA and 2.17 +/- 0.11 ng of HEK293 DNA, while CsCI purification yields 840.27 +/- 76.14 pg of plasmid DNA and 2.43 +/- 0.19 of HEK293 DNA. The two methods produce vectors with similar in vitro and in vivo potencies. The results indicated that the CHT/ANX method is suitable for the scalable purification of the rAAV9 vector. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 50 条
  • [1] PEG-modulated column chromatography for purification of recombinant adeno-associated virus serotype 9
    Zhou, Jingmin
    Yang, Xiao
    Wright, J. Fraser
    High, Katherine A.
    Couto, Linda
    Qu, Guang
    JOURNAL OF VIROLOGICAL METHODS, 2011, 173 (01) : 99 - 107
  • [2] Purification of Adeno-Associated Viral Vector Serotype 9 Using Ceramic Hydroxyapatite Chromatography and its Analysis
    Kurosawa, Yae
    Tsunekawa, Yuji
    Wada, Mikako
    Aizen, Yuko
    Nitahara-Kasahara, Yuko
    Okada, Takashi
    CURRENT PROTOCOLS, 2024, 4 (06):
  • [3] Production and purification of recombinant adeno-associated virus
    Hauswirth, WW
    Lewin, AS
    Zolotukhin, S
    Muzyczka, N
    VERTEBRATE PHOTOTRANSDUCTION AND THE VISUAL CYCLE, PT B, 2000, 316 : 743 - 761
  • [4] Ultracentrifugation-Free Chromatography-Mediated Purification of Recombinant Adeno-Associated Virus Serotype 9 (rAAV9)
    Tomono, Taro
    Hirai, Yukihiko
    Okada, Hironori
    Miyagawa, Yoshitaka
    Adachi, Kumi
    Kawano, Yasuhiro
    Chono, Hideto
    Mineno, Junichi
    Ishii, Akiko
    Shimada, Takashi
    Onodera, Masafumi
    Tamaoka, Akira
    Okada, Takashi
    MOLECULAR THERAPY, 2017, 25 (05) : 149 - 150
  • [5] Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo
    Pacak, Christina A.
    Mah, Cathryn S.
    Thattaliyath, Bijoy D.
    Conlon, Thomas J.
    Lewis, Melissa A.
    Cloutier, Denise E.
    Zolotukhin, Irene
    Tarantal, Alice F.
    Byrne, Barry J.
    CIRCULATION RESEARCH, 2006, 99 (04) : E3 - E9
  • [6] Selective tropism of the recombinant adeno-associated virus 9 serotype for rat cardiac tissue
    Qi, Yanfei
    Liu, Xuan
    Li, Hongwei
    Shenoy, Vinayak
    Li, Qiuhong
    Hauswirth, William W.
    Sumners, Colin
    Katovich, Michael J.
    JOURNAL OF GENE MEDICINE, 2010, 12 (01): : 22 - 34
  • [7] Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy
    Kotulska, Katarzyna
    Fattal-Valevski, Aviva
    Haberlova, Jana
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [8] Scalable Downstream Strategies for Purification of Recombinant Adeno-Associated Virus Vectors in Light of the Properties
    Qu, Weihong
    Wang, Mingxi
    Wu, Yaqing
    Xu, Ruian
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2015, 16 (08) : 684 - 695
  • [9] Scalable Downstream Purification of Recombinant Adeno-associated Viral Vectors
    Schofield, M.
    Marchand, N.
    Kavara, A.
    Hejmowski, A.
    Tansey, S.
    Channawar, R.
    Olson, M.
    MacIntyre, A.
    Huato, J.
    Boenning, K.
    Collins, M.
    Cameau, E.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A106 - A106
  • [10] Herpes Simplex Virus Clearance During Purification of a Recombinant Adeno-Associated Virus Serotype 1 Vector
    Ye, Guo-jie
    Scotti, Marina M.
    Thomas, Darby L.
    Wang, Lijun
    Knop, David R.
    Chulay, Jeffrey D.
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2014, 25 (04) : 212 - 217